-
Archaeological 'breakthrough' could confirm origins of Paris
-
Meta launches camera-free AI glasses amid privacy pushback
-
Australian PM says OpenAI hacked government health website
-
Anthropic touts AI-led biology discovery
-
Rio breaks record for rainiest September amid powerful El Nino
-
Stocks fall on soaring bond yields, higher oil prices
-
Mandela Digital Extends Early Access Programme to 11 February 2027 Following Strong Response
-
ArcPoint Expands Globally with Institutional Intelligence Platform for Modern Investors
-
McDonald's to boost franchisees as inflation weighs on consumers
-
Outgoing UN chief makes final climate push at New York summit
-
Archaelogical 'breakthrough' could confirm origins of Paris
-
Stocks dip, oil soars despite Trump hailing "productive" Iran talks
-
Fendi brings disco bling, Italian style, to Milan Fashion Week
-
أليكس بودي والبروفيسور الدكتور شتيفان هاوبت يتفقان على التعاون من أجل مجموعة فنية أسطورية في رومانيا
-
アレックス・ボディ氏とシュテファン・ハウプト教授、ルーマニアの伝説的な美術コレクションをめぐり提携に合意
-
Alex Bodi și prof. dr. Stefan Haupt încheie un acord de cooperare pentru o colecție de artă legendară în România
-
Stocks dip, oil rises as traders eye chances of Iran deal
-
Blueberry Strengthens MENA Presence with CMA Category 5 License and Dubai Office Launch
-
Oil falls, stocks steady as Trump hails 'good' Iran talks
-
In first, French presidential candidate gives birth during campaign
-
Canada judge to decide prison term for suicide poison seller
-
A Full Moon for Every Child: STARTRADER's STARCARES Brings Support to SOS Children's Village Ho Chi Minh City
-
Meta leans into AI, smart glasses amid privacy pushback
-
Mongolian herders enlist new tech against harsher, drier climate
-
Oil prices fall after Trump hails 'good' talks with Iran
-
Tata turmoil shines light on India succession woes
-
AI political ads warp reality ahead of US midterms
-
OMP and PwC Alliance Moves Process Manufacturers from Siloed Supply Chain Planning to Unified Decisions
-
Oil prices retreat as markets welcome US-Iran talks
-
Chile's Atacama Desert blossoms with life after El Nino rains
-
French prosecutors probe secret filming of women with smart glasses
-
Drug cocktail killed former child star Hayden Panettiere: coroner
-
Trump renames AI "super intelligence," rejects international oversight
-
Trump rejects international regulation of AI
-
How is the EU approaching record fuel prices?
-
Oil prices slide, AI stock buzz fades
-
11 hurt as teen opens fire outside school in western Turkey
-
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
-
UN chief says 'Big Oil' treats atmosphere as open sewer
-
Tunisia says 2026 summer hottest on record
-
Memoir by Diana's brother goes on sale after rocking UK monarchy
-
Houthis accuse Saudi Arabia of deadly strikes as thousands flee
-
Stocks climb as oil slides, AI buzz returns
-
STARTRADER Expands Its Chinese Equity CFD Range with CXMT and Unitree Robotics
-
MEXC Launches “Real Stocks, Real Friends” with Rewards for Bringing Friends to Wall Street
-
MEXC Expands Opportunity Compass with Stock Trading Handbook to Help Crypto Users Build Investment Knowledge
-
Stocks rise on AI buzz, oil prices cool
-
Typhoon Dujuan leaves four dead in Japan, 45,000 houses without power
-
In Bangladesh, Pakistan's Jinnah photo stirs anger
-
Stocks rise on AI buzz, drop in oil prices
'Ketamine Queen' to plead guilty over drugs that killed Matthew Perry
A dealer dubbed the "Ketamine Queen" has agreed to plead guilty to supplying the drugs that killed "Friends" actor Matthew Perry, the US Department of Justice said Monday.
Jasveen Sangha, 42, will admit several charges, including one of distribution of ketamine resulting in death or serious bodily injury in relation to the late star.
Sangha, who is expected to formally enter her pleas in the coming weeks, is a dual citizen of the United States and the United Kingdom. She has been in federal custody since August 2024.
She will become the fifth person to admit playing a part in the death of the beloved actor, who had openly struggled for decades with substance addiction.
Perry was found dead in the hot tub of his Los Angeles home in 2023 at the age of 54.
A criminal investigation was launched soon after an autopsy discovered he had high levels of ketamine -- an anesthetic -- in his system.
Last month Dr Salvador Plasencia pleaded guilty to four counts of distribution of ketamine in the weeks before Perry's death.
Another doctor, Mark Chavez, admitted last year to conspiring to distribute ketamine to Perry.
Plasencia allegedly bought ketamine off Chavez and sold it to the American-Canadian actor at hugely inflated prices.
"I wonder how much this moron will pay," Plasencia wrote in one text message.
According to her plea agreement, Sangha worked with a middleman, Erik Fleming, to sell 51 vials of ketamine to Perry's live-in personal assistant, Kenneth Iwamasa.
Iwamasa repeatedly injected Perry with the ketamine that Sangha supplied, including on October 28, 2023, when he administered at least three shots of Sangha's ketamine, which killed the actor.
The Department of Justice said when she heard news reports about Perry's sudden death, Sangha tried to cover her tracks.
"Delete all our messages," she instructed Fleming.
Perry had been taking ketamine as part of supervised therapy for depression.
But prosecutors say that before his death he became addicted to the substance, which also has psychedelic properties and is a popular party drug.
"Friends," which followed the lives of six New Yorkers navigating adulthood, dating and careers, drew a massive following and made megastars of previously unknown actors.
Perry's role as the sarcastic man-child Chandler brought him fabulous wealth, but hid a dark struggle with addiction to painkillers and alcohol.
In 2018, he suffered a drug-related burst colon and underwent multiple surgeries.
In his 2022 memoir "Friends, Lovers and the Big Terrible Thing," Perry described going through detox dozens of times.
"I have mostly been sober since 2001," he wrote, "save for about sixty or seventy little mishaps."
X.Cheung--CPN